News from gw pharmaceuticals plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 07, 2016, 10:46 ET SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Lawsuit Involving GW Pharmaceuticals plc and a Lead Plaintiff Deadline of March 21, 2016 - GWPH

 The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on...


Feb 19, 2016, 14:47 ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in GW Pharmaceuticals plc of Class action Lawsuit and Upcoming Deadline - GWPH

 Pomerantz LLP announces that a class action lawsuit has been filed against GW Pharmaceuticals plc ("GW Pharmaceuticals" or the "Company")...


Feb 09, 2016, 13:44 ET SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In GW Pharmaceuticals plc To Contact The Firm Before Lead Plaintiff Deadline

NEW YORK, Feb. 9, 2016 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in GW...


Jan 22, 2016, 17:00 ET Bernstein Liebhard LLP Announces That A Suit Has Been Filed Against GW Pharmaceuticals plc

 Bernstein Liebhard LLP today announced that a securities class action has been filed in the United States District Court for the Southern...


Jan 13, 2016, 15:22 ET SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of GW Pharmaceuticals PLC (GWPH)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of GW...


Jan 13, 2016, 15:06 ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of GW Pharmaceuticals plc - GWPH

Pomerantz LLP is investigating claims on behalf of investors of GW Pharmaceuticals plc ("GW Pharmaceuticals" or the "Company") (NASDAQ: GWPH)....


Jan 11, 2016, 13:48 ET GW Pharmaceuticals plc Investigated For Potential Securities Law Violations By Block & Leviton LLP

GW Pharmaceuticals plc ("GW Pharma" or the "Company") (NASDAQ:  GWPH) has dropped precipitously in early trading.  It was down as much as...


May 05, 2015, 16:01 ET GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market

GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and...


Apr 28, 2015, 19:29 ET GW Pharmaceuticals plc Announces Pricing of U.S. Public Offering of ADSs Raising $179.2 Million on NASDAQ Global Market

 GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and...


Jan 08, 2014, 23:05 ET GW Pharmaceuticals plc Announces Pricing of U.S. Follow-On Offering of ADSs Raising $87.9 Million on NASDAQ Global Market

 GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on...


Dec 20, 2013, 09:07 ET GW Pharmaceuticals Files Registration Statement for Proposed Follow-On Offering

GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and...


Dec 11, 2013, 02:00 ET GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma

 GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and...


Dec 02, 2013, 02:00 ET GW Pharmaceuticals to Present at the Piper Jaffray 25th Annual Health Care Conference

GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing...